WHO: Pause in AstraZeneca's COVID-19 vaccine trial shows it is well-run

Dhwani Mehta FXStreet

“The pause in AstraZeneca's COVID-19 vaccine trial shows it is a 'well-run' trial,” World Health Organisation (WHO) said in a statement on Tuesday.

The WHO, further, said that the pause showed that they have looked at safety in 'an appropriate manner'.

Last week, AstraZeneca and the University of Oxford announced that they had stopped the key phase 3 trials of a coronavirus vaccine after a participant was found to have an inflammatory syndrome that affects the spinal cord.

Over the weekend, the British pharma company said that they have been given a go-ahead to restart the vaccine trials in the UK.

Market reaction

The market mood is already upbeat and therefore the comments from WHO add to the optimism.

AstraZeneca plc is gaining 2.50% to regain 8,600 levels, at the time of writing.

S&P 500 futures rally 0.68%, approaching the 3,400 mark. AUD/USD trades close to weekly tops of 0.7336, up 0.51% on the day.

Author

Dhwani Mehta

FXStreet

Residing in Mumbai (India), Dhwani is a Senior Analyst and Manager of the Asian session at FXStreet. She has over 10 years of experience in analyzing and covering the global financial markets, with specialization in Forex and commodities markets.

EUR/USD flat lines near 1.1800 as traders brace for US PPI release

The EUR/USD pair trades on a flat note near 1.1800 during the early Asian session on Friday. The pair steadies as softer Eurozone inflation offsets US tariff uncertainties. Traders await the preliminary reading of the Consumer Price Index from Germany on Friday for more clues about the pace of future policy easing. On the US front, the Producer Price Index report will be released.

GBP/USD declines below 1.3500 on UK political uncertainty, US PPI data eyed

The GBP/USD pair loses ground to near 1.3485 during the early Asian session on Friday. The Pound Sterling weakens against the Greenback amid rising UK political uncertainty surrounding the Gorton and Denton by-election.

Gold awaits acceptance above $5,200 and US PPI data

Gold consolidates previous rebound near $5,200 amid risk-off markets, awaiting US PPI release. The US Dollar eyes a flattish weekly close as dovish Fed outlook and tariff woes outweigh geopolitical risks. Gold yearns for acceptance above $5,200 to resume the uptrend, with a bullish RSI in play.

Top Crypto Gainers: Stable and Decred rally, Pippin approaches record highs

Altcoins, such as Stable, Decred, and Pippin, are extending gains so far this week, defying the risk-averse conditions in the broader cryptocurrency market. Stable and Pippin are near record high levels, while Decred extends its breakout rally above $30.

Changing the game: International implications of recent tariff developments

The Supreme Court ruling on International Emergency Economic Powers Act (IEEPA) tariffs provides limited relief for the rest of the world, with weighted average tariff rates modestly lower.

Starknet unveils strkBTC, shielded Bitcoin transactions on Ethereum Layer 2

Starknet, the Ethereum Layer 2 network developed by StarkWare, today announced strkBTC, a wrapped Bitcoin asset that introduces optional shielding while preserving full DeFi composability.